measurement of radiation exposure to caregivers of patients with thyroid diseases treated with iodine-131: a review

This review paper aimed to examine radiation safety issues related to relatives as well as caregivers of patients with thyroid diseases treated with radioiodine (i-131). during i-131 therapy for thyroid disorders such as hyperthyroidism, patients receiving i-131 doses (200-800 mbq) emit radioactive radiations which pose a prospective risk to other people. critical groups are patients’ visitors and families, especially children. following the updated international guidelines, the doses received by members of the public as a proportion of the therapy of a patient have been decreased. the public annual dose limits are 1 msv, although higher doses are permitted for adults in the patient’s family, provided that the maximum 5 msv is not surpassed for 5 years. without compliance with the current recommendations, extended hospitalizations for patients are essential. family members should therefore limit close interactions with an individual for some duration following thyroid therapy with i-131.